J. M. Santos and M. O. G. Mauro Oscar Grossmann, “Systematic review: cost-benefit of Dapagliflozin versusSacubitril/Valsartan in HFrEF”, Interamerican Journal of Health Sciences, vol. 3, p. 149, Apr. 2023, doi: 10.59471/ijhsc2023149.